Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 31;13:2667–2676. doi: 10.2147/OTT.S240734

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Yang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

KIF4A promotes ccRCC cell proliferation in vitro. (A) HTB-47 and CRL-1932 cells transfected with control or KIF4A shRNA, and the proliferation capacity was quantified by colony formation assays. (B) The results of MTT assays showed the inhibition of cell proliferation caused by KIF4A depletion. (C) Immunoblot assays showed Ki67 expression level in control or KIF4A knockdown HTB-47 and CRL-1932 cells. (D) Immunoblot assays revealed the expression level of PCNA in control or KIF4A ablation ccRCC cells. Results are presented as mean ± SD, *P < 0.05.